Search Results for: VISCHER

Deal & transactions

Vischer advises Medartis on its stake expansion in KeriMedical 

Basel-based orthopedic firm, Medartis, has successfully completed the acquisition of an additional 18% stake in Geneva-based implant manufacturer, KeriMedical, for approximately CHF 18 million. This deal will raise Medartis’ stake to 47%, further cementing the company’s commitment to becoming a one-stop-shop for hand and wrist solutions, as well as increasing its presence in extremity joint […]

Corporate Pharma

Vischer advises Oculis on its public listing on Nasdaq

Oculis Holding, a global biopharmaceutical company, purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”). At closing, Oculis had a pro-forma enterprise value of approximately USD 220m and a cash balance exceeding USD 117m prior to payment of […]


Vischer advises CODE41 in its issuance of tokenised securities

CODE41, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form of ledger-based securities, thanks to the tokenisation technology of Taurus and the opensource smart contract published by CMTA. VISCHER has advised CODE41 in the process. The team was led by partner Maxime Chollet (corporate/m&a, pictured) and included […]

Capital Markets

Vischer advises Fangda on GDR Offering and Listing on SIX 

Fangda Carbon New Material Co., an integrated carbon materials producer in in the People’s Republic of China with diversified product offerings, including graphite electrodes, carbon blocks, isostatic graphite and iron ore concentrates, sold 22m global depositary receipts (GDRs) at an offer price of USD 8.63 per GDR and listed on 15 March 2023 a total […]

Corporate Pharma

Baker McKenzie and Vischer on SHS’s investment in Simulands

The German life science and medtech private equity firm SHS Capital has made a EUR 10 million investment in Simulands, a Swiss manufacturer of simulation devices for medical training of cardiovascular interventions. The investment aims to accelerate the commercialization of this early-stage company and to help it revolutionize cardiovascular education and training. Simulands plans to […]


Tobias F. Rohner new partner at VISCHER

Tobias F. Rohner has joined VISCHER as a partner on 1 February 2023 strengthening the tax team. As a partner in the Zurich office he is co-head of the tax team. With more than 20 years of experience as a tax lawyer, Rohner has excellent expertise in advising international and domestic companies, start-ups, fund and […]

Banking & Finance

VISCHER advises Oberland Capital on its agreement with Helsinn

As we have informed here, the Helsinn Group has closed a financing agreement with Oberland Capital Management. In this sense, VISCHER has advised Oberland Capital Management on its financing agreement with the Ticino based group. Oberland Capital is a private investment firm with assets under management in excess of USD 3 bn, focused exclusively on investing […]

Deal & transactions

Vischer advises E3 Holding on its acquisition of Clean-Tek Group

The German company E3 Holding has acquired the clean-tek group from Felix Ritter. Clean-tek, based in Germany and Basel, is a leading manufacturer of modern cleanroom systems that uses technology for sensitive areas such as pharmaceutical production, medical technology, biotechnology or microelectronics. The company was founded in Renningen in 1986 by Albrecht Ritter, the father […]


Vischer advises AMR Action Fund on its investment in BioVersys

As we have informed here, the AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing antimicrobials, has invested in BioVersys, a clinical-stage company based in Basel, Switzerland. The transaction marks the Fund’s first investment in Europe and is an important step toward building an international portfolio of companies that […]


Boris Räber new partner at Advokatur am Rosenberg

Boris Räber joins Advokatur am Rosenberg from Walder Wyss, where he becomes a partner. He has many years of experience in national and international m&a transactions as well as private equity and venture capital transactions. As an experienced corporate lawyer, Boris Räber regularly advises start-ups and investors on financings (equity and debt), participation plans, exits […]

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio